• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bayesian network analyses in atrial fibrillation - A path to better therapies?心房颤动中的贝叶斯网络分析——通向更好治疗方法的途径?
Int J Cardiol Heart Vasc. 2019 Mar 4;22:210-211. doi: 10.1016/j.ijcha.2019.02.009. eCollection 2019 Mar.
2
Long-Term Outcome of Additional Superior Vena Cava to Septal Linear Ablation in Catheter Ablation of Atrial Fibrillation.导管消融治疗心房颤动时额外上腔静脉至间隔线性消融的长期结果。
J Am Heart Assoc. 2019 Nov 19;8(22):e013985. doi: 10.1161/JAHA.119.013985. Epub 2019 Nov 15.
3
The role of superior vena cava in catheter ablation of long-standing persistent atrial fibrillation.上腔静脉在长期持续性心房颤动导管消融中的作用。
Europace. 2017 Oct 1;19(10):1670-1675. doi: 10.1093/europace/euw167.
4
Do we need pharmacological therapy for atrial fibrillation in the ablation era?在消融时代,我们是否需要针对房颤进行药物治疗?
J Interv Card Electrophysiol. 2006 Dec;17(3):189-94. doi: 10.1007/s10840-006-9075-8. Epub 2007 Mar 6.
5
Atrial fibrillation catheter ablation: an updated review of current guidelines and expert consensus documents.心房颤动导管消融:当前指南与专家共识文件的最新综述
Herzschrittmacherther Elektrophysiol. 2019 Dec;30(4):371-376. doi: 10.1007/s00399-019-00651-0. Epub 2019 Nov 15.
6
Transseptal puncture and catheter ablation via the superior vena cava approach for persistent atrial fibrillation in a patient with polysplenia syndrome and interruption of the inferior vena cava: contact force-guided pulmonary vein isolation.经上腔静脉途径行房间隔穿刺和导管消融治疗多脾综合征并下腔静脉中断患者持续性心房颤动:接触力指导下的肺静脉隔离。
Europace. 2017 Jul 1;19(7):1227-1232. doi: 10.1093/europace/euw095.
7
Monitoring Atrial Fibrillation After Catheter Ablation.导管消融术后心房颤动的监测
J Atr Fibrillation. 2014 Apr 30;6(6):1040. doi: 10.4022/jafib.1040. eCollection 2014 Apr-May.
8
Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?心房颤动的遗传学——临床管理的实际应用:如果不是现在,那何时以及如何应用?
Cardiovasc Res. 2021 Jun 16;117(7):1718-1731. doi: 10.1093/cvr/cvab153.
9
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.提高房颤管理质量路线图:第五届房颤网络/欧洲心律协会共识会议纪要
Europace. 2016 Jan;18(1):37-50. doi: 10.1093/europace/euv304. Epub 2015 Oct 18.
10
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.早期诊断和更好的节律管理可改善房颤患者的预后:第 8 届 AFNET/EHRA 共识会议。
Europace. 2023 Feb 8;25(1):6-27. doi: 10.1093/europace/euac062.

引用本文的文献

1
Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci.心房颤动的全基因组关联研究:探寻风险位点的意义
Int J Cardiol Heart Vasc. 2019 Jul 8;24:100397. doi: 10.1016/j.ijcha.2019.100397. eCollection 2019 Sep.

本文引用的文献

1
Computational modeling: What does it tell us about atrial fibrillation therapy?计算模型:它能告诉我们关于房颤治疗的什么信息?
Int J Cardiol. 2019 Jul 15;287:155-161. doi: 10.1016/j.ijcard.2019.01.077. Epub 2019 Jan 25.
2
Networking analysis on superior vena cava arrhythmogenicity in atrial fibrillation.心房颤动中 superior vena cava 致心律失常性的网络分析
Int J Cardiol Heart Vasc. 2019 Feb 2;22:150-153. doi: 10.1016/j.ijcha.2019.01.007. eCollection 2019 Mar.
3
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation.基于数据的与普遍存在的心房颤动相关的循环血液生物标志物的发现和验证。
Eur Heart J. 2019 Apr 21;40(16):1268-1276. doi: 10.1093/eurheartj/ehy815.
4
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation.伴有和不伴有心房颤动的心力衰竭患者心房的促纤维化、电活动及钙处理重塑
Front Physiol. 2018 Oct 9;9:1383. doi: 10.3389/fphys.2018.01383. eCollection 2018.
5
Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging.用于心房颤动的抗心律失常药物:即将出现新的进展。
Int J Cardiol Heart Vasc. 2018 Sep 13;21:11-15. doi: 10.1016/j.ijcha.2018.08.005. eCollection 2018 Dec.
6
Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios.口服抗凝药在具有复杂情况的心房颤动患者中用于预防卒中。
Int J Cardiol Heart Vasc. 2018 Aug 31;20:56-62. doi: 10.1016/j.ijcha.2018.08.003. eCollection 2018 Sep.
7
Clinical and electrocardiographic characteristics for prediction of new-onset atrial fibrillation in asymptomatic patients with atrial premature complexes.无症状房性早搏患者新发房颤预测的临床及心电图特征
Int J Cardiol Heart Vasc. 2018 May 17;19:70-74. doi: 10.1016/j.ijcha.2018.05.002. eCollection 2018 Jun.
8
Age modifies the risk of atrial fibrillation among athletes: A systematic literature review and meta-analysis.年龄对运动员发生心房颤动的风险具有修饰作用:一项系统文献综述与荟萃分析。
Int J Cardiol Heart Vasc. 2018 Feb 18;18:25-29. doi: 10.1016/j.ijcha.2018.01.002. eCollection 2018 Mar.
9
Translational Challenges in Atrial Fibrillation.心房颤动的转化医学挑战
Circ Res. 2018 Mar 2;122(5):752-773. doi: 10.1161/CIRCRESAHA.117.311081.
10
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.

心房颤动中的贝叶斯网络分析——通向更好治疗方法的途径?

Bayesian network analyses in atrial fibrillation - A path to better therapies?

作者信息

Heijman Jordi, Dobrev Dobromir

机构信息

Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, the Netherlands.

Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.

出版信息

Int J Cardiol Heart Vasc. 2019 Mar 4;22:210-211. doi: 10.1016/j.ijcha.2019.02.009. eCollection 2019 Mar.

DOI:10.1016/j.ijcha.2019.02.009
PMID:30963097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6437288/
Abstract

Despite several major innovations in atrial fibrillation (AF) management, including the improved detection of AF and advances in catheter-ablation-based rhythm control, AF remains a major health-care burden. Recent advances have enabled curation of increasingly large data sets, which, together with improvements in AF detection through screening and continuous rhythm monitoring, enable novel 'big data' approaches to better predict and classify AF. In this issue of the , Drs. Ebana and Furakawa describe an approach to shed light on potential causal links between several risk factors and atrial arrhythmias from the superior vena cava using a Bayesian network analysis. This approach may be a relevant step from statistical association towards identification of causative mechanisms and together with experimental work and mechanistic computer models may help to establish tailored mechanism-based therapies for AF.

摘要

尽管在心房颤动(AF)管理方面有多项重大创新,包括AF检测的改善以及基于导管消融的节律控制方面的进展,但AF仍然是一个主要的医疗负担。最近的进展使得能够整理越来越大的数据集,再加上通过筛查和连续节律监测在AF检测方面的改进,使得新颖的“大数据”方法能够更好地预测和分类AF。在本期杂志中,江波博士和古川博士描述了一种方法,通过贝叶斯网络分析来揭示上腔静脉的几个风险因素与房性心律失常之间潜在的因果联系。这种方法可能是从统计关联迈向确定致病机制的一个相关步骤,并且与实验工作和机制计算机模型一起,可能有助于建立针对AF的基于机制的个性化治疗方法。